Senescence and the SASP: many therapeutic avenues

Jodie Birch1,2, Jesús Gil1,2

  • 1MRC London Institute of Medical Sciences (LMS), London W12 0NN, United Kingdom.

Genes & Development
|December 2, 2020
PubMed

Insights

Cellular senescence, a state of irreversible cell cycle arrest, can be beneficial or detrimental. Targeting the senescence-associated secretory phenotype (SASP) offers a novel therapeutic strategy for age-related diseases.

Area of Science:

  • Cellular biology
  • Aging research
  • Molecular medicine

Background:

  • Cellular senescence is a stress-induced permanent cell cycle arrest.
  • It involves the senescence-associated secretory phenotype (SASP), a bioactive secretome.
  • While acute senescence is protective, chronic senescent cells contribute to age-related diseases.

Purpose of the Study:

  • To summarize the regulation and functions of the SASP.
  • To highlight the therapeutic potential of SASP modulation.
  • To explore SASP-centered approaches as alternatives or complements to senolytics.

Main Methods:

  • Literature review on cellular senescence.
  • Analysis of SASP regulation and functions.
  • Evaluation of therapeutic strategies targeting SASP.

Main Results:

  • SASP comprises various bioactive factors.
  • SASP plays a dual role in health and disease.
  • SASP modulation presents a promising therapeutic avenue.

Conclusions:

  • SASP modulation is a viable senotherapy strategy.
  • Targeting SASP can complement or replace senolytics.
  • Further research into SASP-centered therapies is warranted.